What is Neuroview Technology?
Neuroview Technology operates as a data-driven platform and medical device innovator, dedicated to enhancing neurology outcomes. Its core offering is an implantable, long-term EEG monitor engineered to improve the management of epilepsy and other neurological conditions. By delivering real-time data analytics to both patients and healthcare providers, the company facilitates more informed decision-making and enables personalized patient care. Neuroview Technology's strategic focus is on improving patient quality of life while simultaneously working to reduce the economic burden associated with neurological care.
How much funding has Neuroview Technology raised?
Neuroview Technology has raised a total of $20K across 1 funding round:
Debt
$20K
Debt (2021): $20K with participation from PPP
Key Investors in Neuroview Technology
PPP
Public-Private Partnership
What's next for Neuroview Technology?
With the recent influx of substantial expansion capital, Neuroview Technology is poised for significant growth and market penetration. The company's strategic objective is likely to scale its operations, further develop its innovative EEG monitoring technology, and expand its reach within the healthcare provider and patient communities. This investment at a Series B/C stage suggests a focus on accelerating commercialization and solidifying its position as a leader in neurological data analytics and monitoring solutions.
See full Neuroview Technology company page
